SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-059902
Filing Date
2022-05-13
Accepted
2022-05-13 08:45:19
Documents
15
Period of Report
2022-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215472d1_8k.htm   iXBRL 8-K 32407
2 EXHIBIT 4,1 tm2215472d1_ex4-1.htm EX-4.1 85747
3 EXHIBIT 10.1 tm2215472d1_ex10-1.htm EX-10.1 148551
4 EXHIBIT 99.1 tm2215472d1_ex99-1.htm EX-99.1 12565
  Complete submission text file 0001104659-22-059902.txt   513714

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bstg-20220512.xsd EX-101.SCH 3033
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstg-20220512_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstg-20220512_pre.xml EX-101.PRE 22595
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2215472d1_8k_htm.xml XML 3161
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 22920393
SIC: 3841 Surgical & Medical Instruments & Apparatus